SUMMARY A prospective random double-blind controlled trial comparing the efficacy of cefaclor with that of co-trimoxazole in the treatment of otitis media was undertaken. Two hundred and twenty-three children aged 12 years or younger were studied. Both drugs were effective, with clinical cure or improvement in more than 90 % of the children. The level of compliance was high and side effects few. Both co-trimoxazole and cefaclor can be considered safe and effective drugs for the reatment of acute otitis media.
In paediatric practice, acute otitis media is the third most common reason for consultation with a doctor.' In a number of studies in which myringotomy or aspiration cultures were taken, Haemophilus influenzae, especially in younger children, was found not only to be a common pathogen, but also one that is developing increasing ampicillin resistance.-4 Thus, not only is acute otitis media common, but the most frequently used drug is not as efficacious as it was.
It seemed desirable to assess the effectiveness of two drugs, which, in Canada at least, are not widely used for the treatment of acute otitis medianamely, cefaclor and co-trimoxazole. A review of the literature showed very few random, double-blind, controlled trials with large sample size designed to assess the effectiveness of antimicrobial therapy in otitis media; in particular, there have been no previous studies comparing cefaclor with cotrimoxazole.
Schwartz et al.3 in a small series found that clinical failures after ampicillin were due to ampicillin-resistant H. influenzae cultured after tympanocentesis; 93 % of these children responded to cotrimoxazole.
McLinn,5 in a non-double-blind study found cefaclor more efficacious than amoxycillin, but the results were not statistically significant. He suggests that cefaclor is more efficacious than co-trimoxazole because it attacks not only H. influenzae, but also group A beta haemolytic streptococci and Staphylococcus aureus, less common but also important pathogens.
In another study, McLinn6 found the recurrence rate after amoxycillin was twice as great as after cephradine. That study was not double-blind and the sample was small.
With this knowledge, we set out to answer the following questions; firstly, are cefaclor and cotrimoxazole effective in the treatment of acute otitis media in children, and secondly, if so, is one better than the other?
Subjects and methods
Six paediatricians in busy private primary care paediatric practices agreed to enrol their patients with acute otitis media into the study. These paediatricians were experienced in seeing many children with otitis media (mean number of years in practice= 17, range 5 to 25) and their practices ranged in location from the centre of a large industrial city to an affluent suburban area. Since Canada has universal health care and all patients are private ones, we felt our patients were representative.
All children in the 6 practices who were diagnosed as having acute otitis media, who were 12 years of age or younger, who had not received treatment with antibiotics within the previous 7 days, who had never had otic surgery, and who had had 3 episodes or less of acute otitis media in the preceding 6 Several methodological issues arise from this study. The first is that of diagnosis. Although tympanocentesis has been done on at least 2500 children,3 it is painful and is not necessary for routine clinical practice. Without tympanocentesis and the isolation of bacteria, the diagnosis of acute otitis media is subjective. We hoped to be able to do this study under normal conditions in the community; since most paediatricians do not require tympanocentesis to make a diagnosis, and since it may be assumed that practice, whereas not making perfect at least makes less imperfect, we chose experienced primary care paediatric practitioners rather than paediatric interns or residents in a paediatric outpatient clinic. In addition, observer variation was the same for both groups of children, since it was the children who were randomly allocated to treatment groups, and not the doctors. Since the physicians did not know to which group the children would be assigned, it is safe to assume that the same number of falsepositive diagnoses was assigned to both groups.
The second issue has to do with the use of the pure-tone audiogram as opposed to impedence audiometry as one of the outcome measures. We feel that impedence audiometry is too sensitive and does not really tell us what we want to knownamely, can the child hear? Undoubtedly, had we used impedence audiometry we would have found many more children with evidence of residual serous otitis media, but since there is no evidence that treating children with serous otitis who hear normally is of long-lasting value, we chose puretone audiometry.
The third issue is the absence of a placebo group. We felt this would have been unethical, since the whole course of children with otitis media has changed greatly since effective antibiotic therapy. Mastoid disease and the chronic perforated drum are rare among well-nourished children who have easy access to health care, perhaps owing to early and effective antimicrobial therapy. Although a recent Dutch study suggests that antibiotics are not necessary in acute otitis media,7 that work has been seriously questioned by others. 8 9 The fourth issue is the absence of ampicillin or amoxycillin as a control group. We considered the sample size to include this treatment group would have to be so large as to make the study impractical.
Conclusions
In the first random, double-blind, controlled trial comparing co-trimoxazole with cefaclor in the treatment of acute otitis media in children, both drugs were found to be effective and with few side effects. Compliance was high in both treatment groups. Both drugs can be recommended as effective and safe in the treatment ofchildhood otitis media.
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